Daniel Shevrin to 5-alpha Reductase Inhibitors
This is a "connection" page, showing publications Daniel Shevrin has written about 5-alpha Reductase Inhibitors.
Connection Strength
0.244
-
5a-Reductase inhibition coupled with short off cycles increases survival in the LNCaP xenograft prostate tumor model on intermittent androgen deprivation therapy. J Urol. 2015 Apr; 193(4):1388-93.
Score: 0.128
-
5a-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models. Endocrinology. 2013 Jul; 154(7):2296-307.
Score: 0.116